General information
Title
Elimination de la maladie du sommeil en RD Congo avec l'IMT orienté sur l'élimination de la transmission en collaboration avec la CTB pour l'intégration dans le système des soins de santé primaire - Phase II
ID
XM-DAC-2-10-5294
CRS ID
2021C05294
Start date
End date
Activity status
Implementation
Budget
€5.600.000
Actor
ITM Institute of Tropical Medicine ANTWERPEN - ANVERS
Country
CONGO (DEMOCRATIC REP.)
Sector
Health - Basic Health - Infectious disease control
Aid type
Project-type interventions
Priority partner country
Yes
Fragile state
Yes
Least developed country
Yes
Budgetline
54 16 356049 Society-building and good governance
Finance type
GRANT
Tied status
No
Flow type
ODA
Body
General
Today, the Democratic Republic of the Congo (DRC) is home to over 70 percent of
the world’s cases of sleeping sickness. ITM coordinates the program and assures the research, scientific support, monitoring and evaluation. For the 3rd result, it intends to build an international coalition and delegate activities to other partners who want to join the HAT elimination agenda.
The HAT+ project supports the elimination of Human African Trypanosomiasis (HAT) in DRC.
Results
The specific objective of the HAT+ project is to eliminate HAT transmission in 90% of the endemic Zones de Santé (health districts) of DRC by 2025.
Other
1. The HAT elimination strategy is effectively implemented and reviewed
2. The elimination strategy is supported by targeted research and innovation
3. HAT control activities are integrated in the primary health care system of HAT endemic health districts
4. The progress of HAT elimination is monitored and evaluated